Pfizer (PFE) director adds phantom stock units in Form 4 filing

Q: What insider transaction did Pfizer (PFE) report in this Form 4?

A Pfizer director reported acquiring 1,506.024 phantom stock units on 12/31/2025 as part of deferred director compensation.

Q: What do the reported Pfizer (PFE) phantom stock units represent?

Each unit represents one phantom share of Pfizer common stock , tied to deferred director compensation and related dividend equivalents.

Q: When will the Pfizer (PFE) phantom stock units be settled?

The phantom stock units are to be settled in cash or common stock , at the director's election, following retirement from the Board of Directors .

Q: Is the Pfizer (PFE) director an officer or 10% owner of the company?

The reporting person is listed as a Director of Pfizer Inc. and is not checked as an officer or 10% owner.

Q: Was the Pfizer (PFE) Form 4 filed for one or multiple reporting persons?

The document indicates it is a Form filed by one reporting person , not a joint filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Pfizer Inc. director compensation update: A Pfizer Inc. (PFE) director reported receiving 1,506.024 phantom stock units on 12/31/2025 as part of deferred director compensation. Each unit represents one phantom share of common stock, with the units to be settled in cash or common stock at the director's election following retirement from the Board of Directors. After this transaction, the director beneficially owned 25,349.741 phantom stock units, held in direct form.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Taraporevala Cyrus

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	1,506.024	$24.90	$37K

Holdings After Transaction: Phantom Stock Units — 25,349.741 shares (Direct)

Footnotes (1)

Each unit represents one phantom share of common stock. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

01/05/2026 - 04:57 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taraporevala Cyrus

(Last)

(First)

(Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK

10001-2192

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Phantom Stock Units	⁽¹⁾	12/31/2025		A		1,506.024		⁽²⁾	⁽²⁾	Common Stock	1,506.024	$24.9	25,349.741	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for Cyrus Taraporevala	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Pfizer (PFE) report in this Form 4?

A Pfizer director reported acquiring 1,506.024 phantom stock units on 12/31/2025 as part of deferred director compensation.

How many Pfizer (PFE) phantom stock units does the director now hold?

Following the reported transaction, the director beneficially owned 25,349.741 phantom stock units, held directly.

What do the reported Pfizer (PFE) phantom stock units represent?

Each unit represents one phantom share of Pfizer common stock, tied to deferred director compensation and related dividend equivalents.

When will the Pfizer (PFE) phantom stock units be settled?

The phantom stock units are to be settled in cash or common stock, at the director's election, following retirement from the Board of Directors.

Is the Pfizer (PFE) director an officer or 10% owner of the company?

The reporting person is listed as a Director of Pfizer Inc. and is not checked as an officer or 10% owner.

Was the Pfizer (PFE) Form 4 filed for one or multiple reporting persons?

The document indicates it is a Form filed by one reporting person, not a joint filing.